Clinical Endocrinology 1991: Vol 35 Index

11 Pages·1991·2 MB·English

Clinical Endocrinology (1991) 35, 559-564
Author index to Volume 35
Abdulla A.F. see Ross R.J.M. site on absorption of human growth hormone:
Abedinpour F. see Engelhardt D. abdomen versus thigh 409
Aguayo J. see Baeza A. Besser G.M. see Newbould E.C.
Alberti D. see Giustina A. Besser G.M. see Verhelst J.A.
Alford F. see Page R. Bevan J.S., Ara J., Page M.D., Scanion M.F. & Peters
Amit T., Hertz P., Ish-Shalom S., Lotan R., Luboshitzki J.R. Cholinergic blockade with pirenzepine induces
R., Youdim M.B. & Hochberg Z. Effects of hypo or dose-related reduction in glucose and insulin
hyper-thyroidism on growth hormone-binding responses to a mixed meal in normal subjects and
protein 159 non-insulin dependent diabetics 85
Anyaoku V. see Beshyah S.A. Black E.G. & Sheppard M.C. Serum thyroglobulin
Anyaoku V. see Sharp P.S. measurements in thyroid cancer: evaluation of ‘false’
Ara J. see Bevan J.S. positive results 519
Arce V. see Lima L. Boffa C. see Scacchi M.
Argenio G.F., Bernini G.P., Vivaldi M.S., del Corso C., Boolell M. see Page R.
Santoni R. & Franchi F. Naloxone does not modify Boscaro M. see Sonino N.
fenfluramine-induced prolactin increase in obese Bossoni S. see Giustina A.
patients 505 Bouloux P.M.G. see Newbould E.C.
Au K.M. see Panesar N.S. Brain C.E. see Hindmarsh P.C.
Aurbach G.D. see Marx S.J. Brideau N.-A. see Lemay A.
Brook C.G.D. see Hindmarsh P.C.
Brook C.G.D. see Matthews D.R.
Baeza A., Aguayo J., Barria M. & Pineda G. Rapid
Brown R.S. see Klein R.Z.
preoperative preparation in hyperthyroidism 439
Buchanan C.R. see Ross R.J.M.
Baird D.T. see Hillier $.G.
Buchanan C.R., Maheshwari H.G., Norman M.R..,
Balen A.H. & Jacobs H.S. Commentary: Gonadotrophin
Morrell D.J. & Preece M.A. Laron-type dwarfism
Surge Attenuating Factor: a missing link in the with apparently normal high affinity serum growth
control of LH secretion? 399
hormone-binding protein 179
Bangah M.L. see MacNaughton J.A. Burger H.G. see MacNaughton J.A.
Barbe P. see Bennet A. Burger H.G., Kovacs G.T., Polson D.M., McDonald
Barria M. see Baeza A. J.M., McCloud P.I., Harrop M., Colman P. & Healy
Barth J.H., Cherry C.A., Wojnarowska F. & Dawber D.L. Ovarian sensitization to gonadotrophins by
R.P.R. Cyproterone acetate for severe hirsutism: human growth hormone. Persistence of the effect
results of a double-blind dose ranging study 5 beyond the treated cycle 119
Baylis P.H. see Burrell L.M. Burrai C. see Scacchi M.
Baylis P.H. see Faull C.M. Burrell L.M., Lambert H.J. & Baylis P.H. The effect of
Baylis P.H. see Harvey J.N. drinking on natriuretic peptide, vasopressin and thirst
Baylis P.H. see Thompson C.J. appreciation in hyperosmolar man 229
Belchetz P.E. see Harvey J.N. Butler J. see Ewins D.L.
Belchetz P.E. see Orme S.M. Buzi F. see Giustina A.
Bennet A., Lacaze J.Cl., Caron Ph., Berrada R., Barbe P.
& Louvet J.P. Correlations between mean LH levels
and LH pulse characteristics: differences between Cabezas Agricola J. see Lado Abeal J.
normal and anovulatory women 431 Cabezas-Cerrato J. see Lado Abeal J.
Berg A. see ROjdmark S. Campbell G. see Marx S.J.
Bernini G.P. see Argenio G.F. Caron Ph. see Bennet A.
Berrada R. see Bennet A. Carrier E. see Girardin E.
Bertagna X. see Vieau D. Casanueva F.F. see Muruais C.
Beshyah S.A., Anyaoku V., Niththyanathan R., Sharp P. Cavagnini F. see Scacchi M.
& Johnston D.G. The effect of subcutaneous injection Challeton C. see Mechelany C.
560 Author index
Cherry C.A. see Barth J.H. Erkelens D.W. see Zelissen P.M.J.
Chong P. see Jung R.T. Erster B. see Laron Z.
Christiansen C. see Schlemmer A. Espiner E.A. see Wittert G.A.
Chung Song see Ellyin F.M. Evans A.J., Willis D.S. & Wood P.J. The assay of urinary
Colman P. see Burger H.G. growth hormone in normal and acromegalic
Comoy E. see Mechelany C. adults 413
Cordido F. see Muruais C. Evans B.A.J. see Stillman S.C.
Evans M.J. see Wittert G.A.
Ewins D.L., Rossor M.N., Butler J., Roques P.K., Mullan
Dacie J.E. see Newbould E.C.
M.J. & McGregor A.M. Association between
Damjanovic S. see Popovic V.
autoimmune thyroid disease and Familial Alzheimer’s
Danesi L. see Scacchi M.
disease 93
Davies T.F. see Kendler D.L.
Dawber R.P.R. see Barth J.H.
Faix J.D. see Klein R.Z.
De Martin M. see Scacchi M.
Farquharson M.A. see McNicol A.M.
Dechaud H. see Girardin E.
Farrar J.J. & Toft A.D. Current therapy: Iodine-131
del Corso C. see Argenio G.F.
treatment of hyperthyroidism: current issues 207
Devesa J. see Lima L.
Faull C.M., Rooke P. & Baylis P.H. The effect of a highly
Diaz M.J. see Lima L.
significant serotonin agonist on osmoregulated
Dieguez C. see Muruais C.
vasopressin secretion in healthy man 423
Dieguez C. see Valcavi R.
Feldt-Rasmussen U. see Hegedus L.
Djurovic M. see Popovic V.
Fiad T.M. & McKenna T.J. Meningitis as a late
Dodin S. see Lemay A.
complication of surgically and medically treated
Doga M. see Giustina A.
pituitary adenoma 419
Donald R.A. see Wittert G.A.
Forest J.-C. see Lemay A.
Donaldson A., Nicolini U., Symes E.K., Rodeck C.H. &
Forni L. see Scacchi M.
Tannirandorn Y. Changes in concentrations of
Fowler P.A. & Templeton A.A. Commentary: Ovarian
cortisol, dehydroepiandrosterone sulphate and
response to gonadotrophins: effects of growth
progesterone in fetal and maternal serum during
hormone 117
pregnancy 447
Franchi F. see Argenio G.F.
Dotti C. see Valcavi R.
Franks S. see Sharp P.S.
Dubini A. see Scacchi M.
Freeman E. see Ross R.J.M.
Dunger D.B., Villa A.K., Matthews D.R., Edge J.A.,
Fukata Jun-Ichi see Imura Hiroo
Jones J., Rothwell C., Preece M.A. & Robertson
W.R. Pattern of secretion of bioactive and
Gallisai D. see Scacchi M.
immunoreactive gonadotrophins in normal pubertal
Garoscio-Cholet M. see Girardin E.
children 267
Girardin E., Garoscio-Cholet M., Dechaud H., Lejeune
Durbaba M. see Popovic V.
L., Carrier E., Tourniaire J. & Pugeat M.
Glucocorticoid receptors in lymphocytes in anorexia
Edge J.A. see Dunger D.B. nervosa 79
Edwards C.R.W. see Thompson C.J. Girelli A. see Giustina A.
Edwards C.R.W. see Walker B.R. Giustina A., Girelli A., Alberti D., Bossoni S., Buzi F..,
Ellis M.J. see Wittert G.A. Doga M., Schettino M. & Wehrenberg W.B. Effects
Ellyin F.M., Potchynok A. & Chung Song. Long-term of pyridostigmine on spontaneous and growth
follow-up of hypothalamic-pituitary function in hormone-releasing hormone stimulated growth
patients with transsphenoidal pituitary herniation and hormone secretion in children on daily glucocorticoid
midfacial anomalies 263 therapy 491
Engelhardt D., Weber M.M., Miksh T., Abedinpour F. & Graves M.P. see Wittert G.A.
Jaspers C. The influence of ketoconazole on human Grossman A.B. see Newbould E.C.
adrenal steroidogenesis: incubation studies with tissue Grossman A.B. see Verhelst J.A.
slices 163 Guerin M.V. see Matthews C.D.
Author index 561
Haboubi N.Y. see Rahman Q. Jacobi J. see Parfitt A.M.
Hackeng W.H.L. see Lips P. Jacobs H.S. see Balen A.H.
Haddow J.E. see Klein R.Z. Jacobs H.S. see Owen E.J.
Hansen B.M. see Hegediis L. Jaspers C. see Engelhardt D.
Hansen J.M. see Hegediis L. Jeffcoate W.J. see Patel S.R.
Harrop M. see Burger H.G. Jenkins J.S. Commentary: Thirst and vasopressin 219
Harvey J.N., Nagi D.K., Baylis P.H., Wilkinson R. & Jensen L.T. see Laron Z.
Belchetz P.E. Disturbance of osmoregulated thirst Johansen J.S. see Schlemmer A.
and vasopressin secretion in thyrotoxicosis 29 Johnston D.G. see Beshyah S.A.
Hassager C. see Schlemmer A. Johnston D.G. see Sharp P.S.
Hattori N., Kurahachi H., Ikekubo K.., Ishihara T., Johnston D.G. see Wood D.F.
Moridera K., Hino M., Saiki Y. & Imura H. Effects Jones A. Review: Radiation oncogenesis in relation to the
of sex and age on serum GH binding protein levels in treatment of pituitary tumours 379
normal adults 295 Jones J. see Dunger D.B.
Healy D.L. see Burger H.G. Jones J. see Ross R.
Hegediis L., Hansen J.M., Feldt-Rasmussen U., Hansen Jorgensen J.O.L. see Schlemmer A.
B.M. & Hgier-Madsen M. Influence of thyroxine Jung R.T. & Chong P. Current therapy: The management
treatment on thyroid size and anti-thyroid peroxidase of obesity 11
antibodies in Hashimoto’s thyroiditis 235
Hermos R.J. see Klein R.Z.
Kalfas A. see Page R.
Hertz P. see Amit T.
Kendler D.L., Rootman J., Huber G.K. & Davies T.F.
Hillier S.G., Wickings E.J., Illingworth P.I., Yong E.L.,
Rapid communication: A 64kDa membrane antigen is
Reichert L.E., Baird D.T. & McNeilly A.S. Control
a recurrent epitope for natural autoantibodies in
of immunoactive inhibin production by human
patients with Graves’ thyroid and ophthalmic
granulosa cells 71
disease 539
Hindmarsh P.C. see Matthews D.R.
Kiddy D.S. see Sharp P.S.
Hindmarsh P.C., Brain C.E., Robinson I.C.A.F.,
Klein R.Z., Haddow J.E., Faix J.D., Brown R.S., Hermos
Matthews D.R. & Brook C.G.D. The interaction of
R.J., Pulkkinen A. & Mitchell M.L. Prevalence of
growth hormone releasing hormone and somatostatin
thyroid deficiency in pregnant women 41
in the generation ofa GH pulse 353
Klinger B. see Laron Z.
Hino M. see Hattori N.
Kopelman P.G. see Weaver J.U.
Hirsch P. see Messinis I.E.
Koppeschaar H.P.F. see Zelissen P.M.J.
Hochberg Z. see Amit T.
Kovacs G.T. see Burger H.G.
Hoier-Madsen M. see Hegediis L.
Kurahachi H. see Hattori N.
Holly J.M.P. see Ross R.J.M.
Howlett T.A. see Verhelst J.A.
Huber G.K. see Kendler D.L. Lacaze J.Cl. see Bennet A.
Hudson P.R. see Rahman Q. Lado Abeal J., Cabezas Agricola J., Paz Carreira J.M. &
Hughes I.A. see Stillman S.C. Cabezas-Cerrato J. Influence of sodium valproate on
late follicular phase pulsatile LH secretion in normal
Ikekubo K. see Hattori N. women 477
Illingworth P.I. see Hillier S.G. Lambert H.J. see Burrell L.M.
Imura H. see Hattori N. Laron Z., Klinger B., Jensen L.T. & Erster B. Biochemical
Imura Hiroo, Fukata Jun-Ichi & Mori Toru Review: and hormonal changes induced by one week of
Cytokines and endocrine function: an interaction administration of rIGF-I to patients with Laron type
between the immune and neuroendocrine systems 107 dwarfism 145
Ish-Shalom S. see Amit T. Lee G.S. see Rahman Q.
Ishihara T. see Hattori N. Lejeune L. see Girardin E.
Ismail I.S., Scanlon M.F. & Peters J.R. Effects of ambient Lemay A., Brideau N.-A., Forest J.-C., Dodin S. &
glycaemic state on growth hormone responsiveness in Maheux R. Cholesterol fractions and apolipoproteins
insulin-dependent diabetes 499 during endometriosis treatment by a gonadotrophin
562 Author index
releasing hormone (GnRH) agonist implant or by McNicol A.M., Walker E., Farquharson M.A. & Teasdale
danazol 305 G.M. Pituitary macroadenomas associated with
Lenne F. see Vieau D. hyperprolactinaemia: immunocytochemical and in-
Leung N.W.Y. see Panesar N.S. situ hybridization studies 239
Lima L., Arce V., Diaz M.J., Tresguerres J.A.F. & Devesa Mechelany C., Schlumberger M., Challeton C., Comoy E.
J. Clonidine pretreatment modifies the growth & Parmentier C. TRIAC (3,5,3’-triiodothyroacetic
hormone secretory pattern induced by short-term acid) has parallel effects at the pituitary and
continuous GRF infusion in normal man 129 peripheral tissue levels in thyroid cancer patients
Lips C.J.M. see Lips P. treated with L-thyroxine 123
Lips P., Netelenbos J.C., Van Doorn L., Hackeng W.H.L. Menczel J. see Marx S.J.
& Lips C.J.M. Stimulation and supression of intact Messinis I.E., Hirsch P. & Templeton A.A. Follicle
parathyroid hormone (PTH 1-84) in normal subjects stimulating hormone stimulates the production of
and hyperparathyroid patients 35 gonadotrophin surge attenuating factor (GnSAF) in
Lloyd H.M. see Parfitt A.M. vivo 403
Lotan R. see Amit T. Micic D. see Popovic V.
Louvet J.P. see Bennet A. Micic J. see Popovic V.
Luboshitzki R. see Amit T. Miell J.P. see Ross R.J.M.
Miksh T. see Engelhardt D.
MacNaughton J.A., Bangah M.L., McCloud P.1. & Mitchell M.L. see Klein R.Z.
Burger H.G. Inhibin and age in men 341 Morales M.J. see Muruais C.
Maheshwari H.G. see Ross R.J.M. Mori Toru see Imura Hiroo
Maheshwari H.G. see Buchanan C.R. Moridera K. see Hattori N.
Maheux R. see Lemay A. Morrell D.J. see Buchanan C.R.
Manojilovic D. see Popovic V. Mullan M.J. see Ewins D.L.
Mantero F. see Sonino N. Muruais C., Cordido F., Morales M.J., Casanueva F.F. &
Marx S.J., Menczel J., Campbell G., Aurbach G.D., Dieguez C. Corticosteroid-induced growth hormone
Spiegel A.M. & Norton J.A. Heterogeneous size of secretion in normal and obese subjects 485
the parathyroid glands in familial multiple endocrine
neoplasia type | 521 Nagi D.K. see Harvey J.N.
Marzano C. see Scacchi M. Netelenbos J.C. see Lips P.
Masala A. see Scacchi M. Newbould E.C., Ross G.A., Dacie J.E., Bouloux P.M.G.,
Mason B.A. see Owen E.J. Besser G.M. & Grossman A.B. The use of venous
Matthews C.D., Guerin M.V. & Wang X. Human plasma catheterization in the diagnosis and localization of
melatonin and urinary 6-sulphatoxy melatonin: bilateral phaeochromocytomas 55
studies in natural annual photoperiod and in extended Nicolini U. see Donaldson A.
darkness 21 Niththyanathan R. see Beshyah S.A.
Matthews D. see Ross R. Noonan K. see Weaver J.U.
Matthews D.R. see Dunger D.B. Norman M.R. see Buchanan C.R.
Matthews D.R. see Hindmarsh P.C. Norman M.R. see Ross R.J.M.
Matthews D.R., Hindmarsh P.C., Pringle P.J. & Brook Northover B. see Price D.E.
C.G.D. A distribution method for analysing the Norton J.A. see Marx S.J.
baseline of pulsatile endocrine signals as exemplified
by 24-hour growth hormone profiles 245 O'Malley B.P. see Price D.E.
McCloud P.I. see Burger H.G. Orme S.M. & Belchetz P.E. Isolated ACTH deficiency 213
McCloud P.I. see MacNaughton J.A. Owen E.J., Torresani T., West C., Mason B.A. & Jacobs
McDonald J.M. see Burger H.G. H.S. Serum and follicular fluid insulin like growth
McGregor A.M. see Ewins D.L. factors I and II during growth hormone co-treatment
McKenna T.J. see Fiad T.M. for in-vitro fertilization and embryo transfer 327
McKenna T.J. Commentary: The use of anti-androgens in
the treatment of hirsutism | Page M.D. see Bevan J.S.
McNeilly A.S. see Hillier $.G. Page M.D. see Valcavi R.
Author index 563
Page R., Boolell M., Kalfas A., Sawyer S., Pestell R., Reichert L.E. see Hillier $.G.
Ward G. & Alford F. Insulin secretion, insulin Robertson W.R. see Dunger D.B.
sensitivity and glucose-mediated glucose disposal in Robertson W.R. see Tsatsoulis A.
Cushing’s disease: a minimal model analysis 509 Robinson I.C.A.F. see Hindmarsh P.C.
Panesar N.S., Au K.M., Leung N.W.Y., Shek C.C. & Rodeck C.H. see Donaldson A.
Swaminathan R. Nephrogenous cyclic AMP in Rojas-Miranda A. see Vieau D.
primary hepatocellular carcinoma patients with or Rojdmark S., Berg A., Réssner S. & Wetterberg L.
without hypercalcaemia 527 Nocturnal melatonin secretion in thyroid disease and
Paoletta A. see Sonino N. in obesity 61
Parfitt A.M. Commentary: Growth hormone and bone Rooke P. see Faull C.M.
remodelling 467 Rootman J. see Kendler D.L.
Parfitt A.M., Willgoss D., Jacobi J. & Lloyd H.M. Cell Roques P.K. see Ewins D.L.
kinetics in parathyroid adenomas: evidence for decline Rosenthal F.D. see Price D.E.
in rates of cell birth and tumour growth, assuming Ross G.A. see Newbould E.C.
clonal origin 151 Ross R.J.M., Miell J.P., Freeman E., Jones J., Matthews
Parmentier C. see Mechelany C. D., Preece M.A. & Buchanan C.R. Critically ill
Patel S.R., Selby C. & Jeffcoate W.J. The short Synacthen patients have high basal growth hormone levels with
test in acute hospital admissions 259 attenuated oscillatory activity associated with low
Paz Carreira J.M. see Lado Abeal J. levels of insulin-like growth factor-1 47
Pedersen S.A. see Schlemmer A. Ross R.J.M., Miell J.P., Holly J.M.P., Maheshwari H.G..,
Perry L. see Verhelst J.A. Norman M., Abdulla A.F. & Buchanan C.R. Levels
Pestell R. see Page R. of GH binding activity, IGFBP-1, insulin, blood
Petakov M. see Popovic V. glucose and cortisol in intensive care patients 361
Peters J.R. see Bevan J.S. Rossner S. see R6jdmark S.
Peters J.R. see Ismail I.S. Rossor M.N. see Ewins D.L.
Pineda G. see Baeza A. Rothwell C. see Dunger D.B.
Polson D.M. see Burger H.G.
Popovic V., Micic D., Damjanovic S., Durbaba M., Saiki Y. see Hattori N.
Petakov M., Zoric S., Djurovic M., Manojilovic D. & Santoni R. see Argenio G.F.
Micic J. GH response to growth hormone releasing Sawyer S. see Page R.
hormone and hypoglycaemia is unaltered by high Scacchi M., Danesi L., De Martin M., Dubini A., Forni
endogenous plasma calcitonin levels in patients with L., Masala A., Gallisai D., Burrai C., Terzoli S.,
medullary thyroid carcinoma 137 Boffa C., Marzano C. & Cavagnini F. Treatment with
Portioli L. see Valcavi R. biosynthetic growth hormone of short thalassaemic
Potchynok A. see Ellyin F.M. patients with impaired growth hormone secretion 335
Preece M.A. see Ross R.J.M. Scanlon M.F. see Bevan J.S.
Preece M.A. see Buchanan C.R. Scanlon M.F. see Ismail IS.
Preece M.A. see Dunger D.B. Scanlon M.F. see Valcavi R.
Price D.E., O'Malley B.P., Northover B. & Rosenthal Schettino M. see Giustina A.
F.D. Changes in circulating thyroid hormone levels Schlemmer A., Johansen J.S., Pedersen S.A., Jorgensen
and systolic time intervals in acute J.O.L., Hassager C. & Christiansen C. The effect of
hypothyroidism 67 growth hormone (GH) therapy on urinary
Pringle P.J. see Matthews D.R. pyridinoline cross-links in GH-deficient adults 471
Pugeat M. see Girardin E. Schlumberger M. see Mechelany C.
Pulkkinen A. see Klein R.Z. Selby C. see Patel S.R.
Shah I.U. see Rahman Q.
Rahman Q.. Haboubi N.Y., Hudson P.R., Lee G.S. & Shalet S.M. see Tsatsoulis A.
Shah I.U. The effect of thyroxine on small intestinal Sharp P.S. see Beshyah S.A.
motility in the elderly 443 Sharp P.S., Kiddy D.S., Reed M.J., Anyaoku V., Johnston
Reed M.J. see Sharp P.S. D.G. & Franks S. Correlation of plasma insulin and
Rees L.H. see Verhelst J.A. insulin-like growth factor-I with indices of androgen
564 Author index
transport and metabolism in women with polycystic Vieau D., Rojas-Miranda A., Verley J.M., Lenne F. &
ovary syndrome 253 Bertagna X. The secretory granule peptides 7B2 and
Shek C.C. see Panesar N.S. CCB are sensitive biochemical markers of neuro-
Sheppard M.C. see Black E.G. endocrine bronchial tumours in man 319
Sonino N., Boscaro M., Paoletta A., Mantero F. & Villa A.K. see Dunger D.B.
Ziliotto D. Ketoconazole treatment in Cushing’s Vivaldi M.S. see Argenio G.F.
syndrome: experience in 34 patients 347
Spiegel A.M. see Marx S.J. Walker B.R. & Edwards C.R.W. Review: 11-
Stewart D.E. see Wittert G.A. Hydroxysteroid dehydrogenase and enzyme-mediated
Stillman S.C., Evans B.A.J. & Hughes I.A. Androgen receptor protection: Life after liquorice? 281
dependent stimulation of aromatase activity in genital Walker E. see McNicol A.M.
skin fibroblasts from normals and patients with Wallis M. Commentary: Growth hormone-binding
androgen insensitivity 533 proteins 291
Swaminathan R. see Panesar N.S. Wang X. see Matthews C.D.
Symes E.K. see Donaldson A. Ward G. see Page R.
Wass J.A.H. see Verhelst J.A.
Tannirandorn Y. see Donaldson A. Weaver J.U., Noonan K. & Kopelman P.G. An
Teasdale G.M. see McNicol A.M. association between hypothalamic-pituitary
Templeton A.A. see Fowler P.A. dysfunction and peripheral endocrine function in
Templeton A.A. see Messinis I.A. extreme obesity 97
Terzoli S. see Scacchi M. Weber M.M. see Engelhardt D.
Thijssen J.H.H. see Zelissen P.M.J. Wehrenberg W.B. see Giustina A.
Thompson C.J., Edwards C.R.W. & Baylis P.H. Osmotic Wells J.E. see Wittert G.A.
and non-osmotic regulation of thirst and vasopressin West C. see Owen E.J.
secretion in patients with compulsive water Wetterberg L. see ROjdmark S.
drinking 221 Wickings E.J. see Hillier $.G.
Toft A.D. see Farrar J.J. Wilkinson R. see Harvey J.N.
Torresani T. see Owen E.J. Willgoss D. see Parfitt A.M.
Tourniaire J. see Girardin E. Willis D.S. see Evans A.J.
Trainer P.J. see Verhelst J.A. Wittert G.A., Stewart D.E., Graves M.P., Ellis M.J.,
Tresguerres J.A.F. see Lima L. Evans M.J., Wells J.E., Donald R.A. & Espiner E.A.
Tsatsoulis A. & Shalet S.M. Antisperm antibodies in the Plasma corticotrophin releasing factor and
polyglandular autoimmune (PGA) syndrome type I: vasopressin responses to exercise in normal man 311
response to cyclical steroid therapy 299 Wojnarowska F. see Barth J.H.
Tsatsoulis A., Shalet S.M. & Robertson W.R. Review: Wood D.F., Johnston J.M. & Johnston D.G. Review:
Bioactive gonadotrophin secretion in man 193 Dopamine, the D2 receptor and pituitary
tumours 455
Valcavi R., Dieguez C., Zini M., Page M.D., Dotti C., Wood P.J. see Evans A.J.
Portioli L. & Scanlon M.F. Effect of pyridostigmine
and pirenzepine on GH responses to GHRH in Yong E.L. see Hillier $.G.
hyperthyroid patients 141 Youdim M.B. see Amit T.
Van Doorn L. see Lips P.
Verhelst J.A., Trainer P.J., Howlett T.A., Perry L., Rees Zelissen P.M.J., Koppeschaar H.P.F., Erkelens D.W. &
L.H., Grossman A.B., Wass J.A.H. & Besser G.M. Thijssen J.H.H. B-Endorphin and adrenocortical
Short and long-term responses to metyrapone in the function in obesity 369
medical management of 91 patients with Cushing’s Ziliotto D. see Sonino N.
syndrome 169 Zini M. see Valcavi R.
Verley J.M. see Vieau D. Zoric S. see Popovic V.
Clinical Endocrinology (1991) 35, 565-568
Subject index to Volume 35
ACTH Cell kinetics
and f-endorphin in obesity 369 in parathyroid adenomas 151
Addison’s disease Children
Synacthen test 259 gonadotrophin secretion in pubertal 267
Adrenal after liver transplant, effect of pyridostigmine on
steroidogenesis, effect of ketoconazole 163 (GHRH-stimulated) GH, with corticosteroid 491
Adrenaline and noradrenaline Cholesterol
in diagnosis of phaeochromocytomas 55 and apolipoproteins in endometriosis treated by GnRH
Age or danazol 305
and inhibin in men 341 Clonidine
Alzheimer’s disease and GH secretion induced by GRF 129
genetic link with autoimmune thyroid disease 93 Cortisol
cAMP response to Synacthen 259
nephrogenous in hepatocellular carcinoma (with cortisone interconversion and 11f-hydroxysteroid
hypercalcaemia) 527 dehydrogenase (Review) 281
Androgen in severely ill 361
insulin and IGF-I in PCOS 253 and f-endorphin in obesity 369
in severely ill 373 CRF
insensitivity, androgen stimulated aromatase activity in and AVP response to exercise in men 311
GSF 533 Critical illness
Anorexia nervosa GH and IGF-I levels in 47
glucocorticoid receptors in lymphocytes in 79 Cushing’s disease/syndrome
ANP response to metyrapone 169
AVP and thirst 229 ketoconazole treatment 347
Antisperm antibodies insulin secretion and sensitivity and glucose disposal:
in PGA, response to steroid 299 minimal model analysis 509
Apolipoprotein Cyproterone acetate
and cholesterol in endometriosis treated by GnRH or for hirsutism 1, 5
danazol 305 Cytokines
Aromatase interaction between immune and endocrine systems
androgen stimulation in GSF from patients with (Review) 107
androgen insensitivity 533
AVP
Danazol
and thirst in thyrotoxicosis 29
treatment of endometriosis cholesterol and
and thirst (Commentary) 219, 221
apolipoprotein in 305
ANP and thirst 229
Diabetic
and CRF response to exercise in men 311
non-insulin dependent, pirenzepine and glucose and
insulin responses 85
Bone effect of glycaemic state on GH responsiveness in 499
remodelling and GH (Commentary) 467 Dopamine
resorption and GH 471 the dopamine D2 receptor and pituitary tumours
Bronchial tumours (Review) 455
neuro-endocrine, secretory granule peptides are
biochemical markers 319 Endometriosis
cholesterol and apolipoprotein in GnRH or danazol
Calcitonin treatment 305
and GH response to GHRH and hypoglycaemia in B-Endorphin
medullary thyroid carcinoma 137 and adrenocortical function in obesity 369
566 Subject index
Exercise and ovarian response: effect of GH (Commentary) 117,
CRF and AVP response in men 311 119
secretion (Review) 193
Fenfluramine secretion in pubertal children 267
-induced PRL in obesity not modified by naloxone 505 Granulosa cells
control of immunoactive inhibin production 71
Genetics Graves’ thyroid and ophthalmic disease
autoimmune thyroid disease link with Alzheimer’s a membrane antigen is an epitope for autoantibodies
disease 93 in 539
Genital skin fibroblasts GRF
androgen dependent aromatase activity in, from patients induced GH secretion, effect of clonidine 129
with androgen insensitivity 533
GH
Hashimoto’s thyroiditis
and IGF-I levels in critical illness 47
influence of thyroxine on thyroid size and anti-thyroid
effect on ovarian response to gonadotrophins
peroxidase antibodies 235
(Commentary) 117, 119
Heart
secretion induced by GRF, effect of clonidine 129
systolic time and thyroid levels in hypothyroidism 67
response to GHRH and hypoglycaemia and calcitonin
Hepatocellular carcinoma
levels in medullary thyroid carcinoma 137
(with hypercalcaemia), nephrogenous cAMP 527
profiles, pulse analysis 245
Hirsutism
co-treatment for IVF and embryo transfer; IGF
anti-androgen treatment (Commentary) |
during 327
cyproterone acetate for 5
treatment of short thalassaemic patients 335
11f-Hydroxysteroid dehydrogenase
pulse, GHRH and somatostatin in generation 353
and enzyme-mediated receptor protection (Review) 281
binding activity in severely ill 361
Hypercalcaemia
and adult bone remodelling (Commentary) 467
with hepatocellular carcinoma, nephrogenous cAMP
and bone resorption markers 471
in 527
corticosteroid-induced and obesity 485
Hyperparathyroidism
secretion in children on glucocorticoid after liver
stimulation and suppression of PTH in 35
transplant, effect of pyridostigmine (and GHRH) 491
Hyperprolactinaemia
responsiveness, effect of glycaemic state in IDDM 499
with pituitary macroadenomas: immunocytochemical
GHBP
and hybridization studies 239
effects of hypo or hyper-thyroidism on 159
Hyperthyroidism
in Laron-type dwarfism 179
effect of pyridostigmine and pirenzepine on GH
(Commentary) 291
response to GHRH in 141
levels, effects of sex and age 295
effect on GHBP 159
GHRH
treatment by iodine-131 (Current therapy) 207
and somatostatin in GH pulse 353
Hypothalamic-—pituitary function
Glucocorticoid
pituitary herniation and midfacial anomalies 263
therapy in children after liver transplant, effects of
Hypothyroidism
pyridostigmine (and GHRH) on GH 491
thyroid hormone levels and systolic time 67
Glucocorticoid receptors
effects on GHBP 159
in lymphocytes in anorexia nervosa 84
Glucose
in severely ill 361 IGF
Glycaemia and GH levels in critical illness 47
effect on GH responsiveness in IDDM 499 biochemical and hormonal changes induced in Laron
GnRH dwarfism 145
treatment of endometriosis; cholesterol and insulin and androgen in PCOS 253
apolipoprotein in 305 during GH co-treatment for IVF and embryo
Gonadotrophins transfer 327
Subject index 567
IGFBP Naloxone
in severely ill 361 not modify fenfluramine-induced PRL in obesity 505
Immune system Neuro-endocrine bronchial tumours
endocrine system and cytokines (Review) 107 secretory granule peptides are biochemical markers 319
Inhibin Nomenclature of thyroid autoantigens and
immunoactive production by granulosa cells 71 autoantibodies 549
and age in men 341
Insulin
IGF-I and androgen in PCOS 253 Obesity
in severely ill 361 management (Current therapy) 11
secretion, sensitivity and glucose disposal in Cushing’s melatonin secretion in 61
disease: minimal model analysis 509 hypothalamic-pituitary dysfunction and peripheral
lodine-131 endocrine function 97
treatment of hyperthyroidism (Current therapy) 207 B-endorphin and adrenocortical function in 369
Isolated ACTH deficiency 213 and corticosteroid-induced GH secretion 485
IVF naloxone not modify fenfluramine-induced PRL in 505
and embryo transfer, IGF during GH co-treatment 327 Ovarian response
to gonadotrophins: effect of GH (Commentary) 117,
Ketoconazole 119
influence on adrenal steroidogenesis 163
treatment of Cushing’s syndrome 347
Parathyroid adenomas
cell kinetics assuming clonal origin 151
Laron type dwarfism PCOS
biochemical and hormonal changes induced by rIGF-I insulin, IGF-I and androgen in 253
in 145 PGA
GHBP in 179
antisperm antibodies in, response to steroid 299
LH
Phaeochromocytomas
pulsatile secretion and sodium valproate in women 477
venous catheterization in diagnosis 55
Liver transplantation Photoperiod
in children, effect of pyridostigmine (and GHRH) on melatonin and 6-sulphatoxy melatonin 21
GH with glucocorticoid 491 Pirenzepine
glucose and insulin responses in NIDDM 85
Melatonin and 6-sulphatoxy melatonin and pyridostigmine, effect on GH response to GHRH in
in natural annual photoperiod and in darkness 21 hyperthyroidism 141
secretion in obesity 61 Pituitary
Men macroadenomas with hyperprolactinaemia:
antisperm antibodies in PGA, response to steroid 299 immunocytochemical and hybridization 239
CRF and AVP response to exercise in 311 herniation, midfacial anomalies and hypothalamic-
inhibin and age in 341 pituitary function 263
Metyrapone tumours, dopamine and the D2 receptor (Review) 455
in Cushing’s syndrome 169 Polydipsia
Midfacial anomalies and AVP secretion 221
pituitary herniation and hypothalamic-pituitary Polyglandular autoimmune syndrome
function 263 antisperm antibodies in and response to steroid 299
Mineralocorticoid receptor Pregnancy
renal, and 11f-hydroxysteroid dehydrogenase thyroid deficiency in 41
(Review) 281 PTH
Minimal model analysis stimulation and suppression in hyperparathyroidism 35
of insulin secretion and sensitivity and glucose disposal Pulsatile endocrine signals
in Cushing’s disease 509 analysis of GH profiles 245
568 Subject index
Pyridostigmine Thyroglobulin
and pirenzepine, effect on GH response to GHRH in evaluation of measurements in thyroid cancer 519
hyperthyroidism 141 Thyroid
and (GHRH-stimulated) GH secretion in children on deficiency in pregnant women 41
glucocorticoid after liver transplant 491 disease, autoimmune, link with Alzheimer’s disease 93
cancer, effects of TRIAC in L-thyroxine treatment 123
Secretory granule peptides carcinoma, GH response to GHRH and hypoglycaemia,
biochemical markers of neuro-endocrine bronchial and calcitonin 137
tumours 319 cancer, evaluation of thyroglobulin measurements 519
Severely ill Thyrotoxicosis
GH binding, IGFBP-1, insulin, glucose and cortisol thirst and AVP secretion 29
in 361 and melatonin secretion in obesity 61
androgens in (Letter) 373 Thyroxine
Sodium valproate treatment of thyroid cancer, effect of TRIAC 123
and pulsatile LH secretion in women 477 effect on thyroid size and anti-thyroid peroxidase
Somatostatin antibodies in Hashimoto’s thyroiditis 235
and GHRH in GH pulse 353 Transsphenoidal pituitary herniation
Steroidogenesis hypothalamic-pituitary function and midfacial
adrenal, effect of ketoconazole 163 anomalies 263
Synacthen TRIAC
test in acute admission 259 effects in thyroid cancer treated with L-thyroxine 123
Systolic time
and thyroid hormone levels in hypothyroidism 67 Women
thyroid deficiency in pregnant 41
Tetracosactrin ovarian response to gonadotrophins: effect of GH
test in acute admission 259 (Commentary) 117, 119
Thalassaemia insulin, IGF-I and androgen in PCOS 253
treatment of short patients with GH 335 endometriosis treatment by GnRH or danazol;
Thirst cholesterol and apolipoprotein in 305
osmoregulation and AVP in thyrotoxicosis 29 IGF during GH co-treatment for IVF and embryo
and AVP (Commentary) 219, 221 transfer 327
ANP and AVP 229 sodium valproate and pulsatile LH secretion in 477